Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future-Reference-Cited by-同舟云学术

Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future

Published:2019-12-30 Issue:2 Volume:36 Page:301-327
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Godman Brian¹²³⁴^ORCID,Haque Mainul⁵^ORCID,McKimm Judy⁶^ORCID,Abu Bakar Muhamad⁷^ORCID,Sneddon Jacqueline⁸,Wale Janney⁹,Campbell Stephen¹⁰¹¹,Martin Antony P.³,Hoxha Iris¹²,Abilova Vafa¹³,Anand Paramadhas Bene D.¹⁴,Mpinda-Joseph Pinkie¹⁵,Matome Matshediso¹⁶,de Lemos Livia Lovato Pires¹⁷¹⁸,Sefah Israel¹⁹^ORCID,Kurdi Amanj¹²⁰^ORCID,Opanga Sylvia²¹,Jakupi Arianit²²^ORCID,Saleem Zikria⁴²³^ORCID,Hassali Mohamed Azmi⁴^ORCID,Kibuule Dan²⁴^ORCID,Fadare Joseph²⁵^ORCID,Bochenek Tomasz²⁶,Rothe Celia²⁶,Furst Jurij²⁷,Markovic-Pekovic Vanda²⁸^ORCID,Bojanić Ljubica²⁹³⁰,Schellack Natalie²^ORCID,Meyer Johanna C.²^ORCID,Matsebula Zinhle³¹,Phuong Thuy Nguyen Thi³²^ORCID,Thanh Binh Nguyen³²,Jan Saira³³³⁴,Kalungia Aubrey³⁵^ORCID,Mtapuri-Zinyowera Sekesai³⁶,Sartelli Massimo³⁷^ORCID,Hill Ruaraidh³⁸^ORCID

Affiliation:

1. Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom;

2. School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa;

3. Health Economics Centre, University of Liverpool, Liverpool, UK;

4. School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia;

5. Unit of Pharmacology, Faculty of Medicine and Defence Health, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kuala Lumpur, Malaysia;

6. Swansea University School of Medicine, Grove Building, Swansea University, Wales UK;

7. Unit of Otolaryngology, Faculty of Medicine and Defence Health, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kuala Lumpur, Malaysia;

8. Healthcare Improvement Scotland, Glasgow, UK;

9. Independent Consumer Advocate, Brunswick, Victoria, Australia;

10. Centre for Primary Care, Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, UK;

11. NIHR Greater Manchester Patient Safety Translational Research Centre, School of Health Sciences, University of Manchester, Manchester, UK;

12. Department of Pharmacy, Faculty of Medicine, University of Medicine Tirana, Tirana, Albania;

13. Analytical Expertise Center, Ministry of Health, Baku, Azerbaijan Republic;

14. Department of Pharmacy, Nyangabgwe Hospital, Francistown, Botswana;

15. Department of Infection Prevention and Control, Nyangabgwe Hospital, Francistown, Botswana;

16. Department of Managed Care, AFA, Gaborone, Botswana;

17. SUS Collaborating Centre for Technology Assessment and Excellence in Health, sala, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Av. Presidente Antônio Carlos, Campus Pampulha, Minas Gerais, CEP, Brazil;

18. Programa de Pós-Graduação em Saúde Pública, Faculdade de Medicina, Universidade Federal de Minas Gerais, Minas Gerais, CEP, Brazil;

19. Department of Pharmacy, Keta Municipal Hospital, Ghana Health Service, Keta, Ghana;

20. Department of Pharmacology, College of Pharmacy, Hawler Medical University, Erbil, Iraq;

21. Department of Pharmacology and Pharmacognosy, School of Pharmacy, University of Nairobi, Nairobi, Kenya;

22. UBT – Higher Education Institute, Prishtina, Kosovo;

23. Hamdard Institute of Pharmaceutical Sciences, Hamdard University, Islamabad, Pakistan;

24. Department of Pharmacy Practice and Policy, Faculty of Health Sciences, University of Namibia, Windhoek, Namibia;

25. Department of Pharmacology and Therapeutics, Ekiti State University, Ado-Ekiti, Nigeria;

26. Department of Drug Management, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland;

27. Health Insurance Institute, Ljubljana, Slovenia;

28. Department of Social Pharmacy, Faculty of Medicine, University of Banja Luka, Banja Luka, Republic of Srpska, Bosnia and Herzegovina;

29. Public Health Institute, Banja Luka, Republic of Srpska, Bosnia and Herzegovina;

30. Department of Pharmacy, Faculty of Medicine, University of Banja Luka, Banja Luka, Republic of Srpska, Bosnia and Herzegovina;

31. Raleigh Fitkin Memorial Hospital, Manzini, Swaziland;

32. Department of Pharmaceutical Administration and PharmacoEconomics, Hanoi University of Pharmacy, Hanoi, Vietnam;

33. Department of Clinical Pharmacy, Rutgers State University of New Jersey, Piscataway, NJ, USA;

34. Department of Pharmacy Strategy and Clinical Integration, Horizon Blue Cross Blue Shield of New Jersey, Newark, NJ, USA;

35. Department of Pharmacy, University of Zambia, Lusaka, Zambia;

36. National Microbiology Reference Laboratory, Harare, Zimbabwe;

37. Department of Surgery, University of Macerata, Macerata Hospital, Macerata, MC, Italy;

38. Liverpool Reviews and Implementation Group, Liverpool University, Liverpool, UK

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2019.1700947

Reference388 articles.

1. Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis

2. Taylor JH, Yerushalmi E, Smith R, et al. Estimating the economic costs of antimicrobial resistance: model and results. 2014. Available from: http://www.rand.org/content/dam/rand/pubs/research_reports/RR900/RR911/RAND_RR911.pdf.

3. O'Neill J. Securing new drugs for future generations: the pipeline of antibiotics. The review of antimicrobial resistance. Available from: https://amr-review.org/sites/default/files/SECURING%20NEW%20DRUGS%20FOR%20FUTURE%20GENERATIONS%20FINAL%20WEB_0.pdf.

4. Antibiotic resistance—the need for global solutions

5. World Bank Group – Drug-resistant infections – a threat to our economic future. Available from: http://documents.worldbank.org/curated/en/323311493396993758/pdf/114679-REVISED-v2-Drug-Resistant-Infections-Final-Report.pdf.

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effective Programmes to Reduce Inappropriate Dispensing of Antibiotics in Community Pharmacies Especially in Developing Countries;Advances in Human Biology;2023-12-26

2. The Disruptive Impact of COVID-19 on the Utilization of Cancer Chemotherapy-Related Healthcare Assistance at the Principal Nationwide Referral Hospital in Kenya;Cureus;2023-12-11

3. Antibiotic consumption for sore throat and the potential effect of a vaccine against group A Streptococcus: a systematic review and modelling study;eBioMedicine;2023-12

4. Tackling antimicrobial resistance in primary care facilities across Pakistan: Current challenges and implications for the future;Journal of Infection and Public Health;2023-12

5. Selling antibiotics without prescriptions among community pharmacies and drug outlets: a simulated client study from Ghana;Expert Review of Anti-infective Therapy;2023-11-20